Clinical Trials Logo

Clinical Trial Summary

Nosocomial infections are increasing rapidly both internationally and domestically, especially carbapenem-resistant Klebsiella pneumoniae infections. However, there were still lack of evidence about the risk and prognosis in Taiwan. The choice of drug and related sensitivity test was also limited. We would analyze the infection risk, prognosis, and drug sensitivity of Klebsiella pneumoniae and focus on strategy to manage carbapenem-resistant Klebsiella pneumoniae infections.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT04337840
Study type Observational
Source National Taiwan University Hospital
Contact Jen-Yu Hsu
Phone 0922868936
Email b94401012@g.ntu.edu.tw
Status Not yet recruiting
Phase
Start date May 5, 2020
Completion date March 2022